Johns Hopkins Kimmel Cancer Center scientists report they have discovered a biochemical process that gives prostate cancer cells the almost unnatural ability to change their shape, squeeze into other organs and take root in other parts of the body. The scientists say their cell culture and mouse studies of the process, which involves a cancer-related...
Tag: <span>Prostate cancer</span>
Osteoporosis medications improve bone health in men with prostate cancer receiving androgen deprivation therapy
Both biophosphonates and denosumab improve bone mineral density (BMD) in men with nonmetastatic prostate cancer who are receiving androgen deprivation therapy (ADT). The results from a systematic review and meta-analysis are published in Annals of Internal Medicine. One in two men with prostate cancer receives ADT at some point after diagnosis. While ADT has been the mainstay of...
Ejaculating at least 21 times a month significantly reduces a man’s risk of prostate cancer
This is compared to men who ejaculate just four-to-seven times a month Ejaculation is protective regardless of whether it’s through sex or masturbation Past research suggests ejaculation rids the gland of cancer-causing substances It may also help to ease inflammation, which is a known cause of the condition Researchers from Harvard University analyzed 31,925 men...
Immunotherapy for prostate cancer: What you need to know
Prostate cancer is one of the most common forms of cancer in American men. The condition affects 1 in 7 men during their lifetime, according to the American Cancer Society. Traditional treatments for prostate cancer include surgery, chemotherapy, and radiation. However, there are emerging therapies that have shown promise in treating prostate cancer. An example is immunotherapy. Immunotherapy is a...
AstraZeneca’s Lynparza Could Be Transformed Into Precision Medicine For Prostate Cancer
Thanks to a new three-in-one blood test, AstraZeneca’s drug Lynparza could be transformed into precision medicine for patients with prostate cancer, researchers said. On Monday, June 19, a newly published study revealed how a blood test that analyzes cancer DNA from patients can revolutionize prostate cancer treatment. AstraZeneca’s Lynparza has long been approved for the treatment...
Blood cell discovery identifies patients with aggressive prostate cancer
Patients who have aggressive prostate cancer could be identified by a highly accurate and simple blood test, according to an early study by Queen Mary University of London (QMUL). The research discovered rare cells in the blood that could be used to identify patients who are 10 times more likely to die of their prostate...
Turmeric, red grape, and apple compounds ‘starve’ prostate cancer cells
What do turmeric, apples, and grapes have in common? According to a new study, they could hold the key to preventing and treating one of the most common cancers in the United States Researchers have identified a number of natural compounds that have the potential to “starve” prostate cancer tumors and shrink them. Compounds present in turmeric,...
Adding abiraterone to standard treatment improves prostate cancer survival by 40 percent
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the 2017 ASCO Annual Meeting in Chicago and published in the New England Journal of Medicine today (Saturday). The results...
Prostate cancer treatment ‘could help more patients’
Image captionHormone therapy stops more testosterone from reaching the prostate gland One of the largest clinical trials for prostate cancer has given “powerful results”, say UK researchers. A drug for treating prostate cancer that has spread was found to save lives when offered earlier, a study found. The trial looked at abiraterone as an additional...
Scientists identify biomarkers to guide hormone therapy for prostate cancer
A test commonly used in breast cancer has been found to also identify which patients with aggressive prostate cancer will benefit from hormonal therapy, according to a study led by scientists at UC San Francisco and the University of Michigan. While hormone therapy has been used successfully to treat many prostate cancer patients, until now, researchers have been...